Findings from a prostate cancer screening program in a Japanese population

Although Asia has a very low incidence of prostate cancer in comparison with other Asian countries, Japan has one of the highest incidence （30.4 per 100 000） and mortality rates （5 per 100 000） from prostate cancer, according to the 2012 GLOBOCAN estimates. Kitagawa et al. conducted a retrospective...

Full description

Saved in:
Bibliographic Details
Published in:Asian journal of andrology 2014-11, Vol.16 (6), p.922-922
Main Authors: Ranasinghe, Weranja K B, Persad, Raj
Format: Article
Language:English
Subjects:
Cancer screening
Humans
Invited
Male
Mortality
Prostate cancer
Prostate-Specific Antigen - blood
Prostatic Neoplasms - immunology
PSA
亚洲国家
人口
前列腺癌
发病率
日本
特异性抗原
筛查
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c568t-7f7a314b65cb5e75e898f3ea59b010b69c1727582ed45359038ab49245353bc53
container_end_page 922
container_issue 6
container_start_page 922
container_title Asian journal of andrology
container_volume 16
creator Ranasinghe, Weranja K B
Persad, Raj
description Although Asia has a very low incidence of prostate cancer in comparison with other Asian countries, Japan has one of the highest incidence （30.4 per 100 000） and mortality rates （5 per 100 000） from prostate cancer, according to the 2012 GLOBOCAN estimates. Kitagawa et al. conducted a retrospective analysis of the populationbased trends of prostate-specific antigen （PSA） screening conducted in men, between the ages of 54 and 69 years in Kanazawa city, which comprises of about a third of the Japanese population. In this annual screening program, they demonstrated a decreasing trend in the median serum PSA levels in men diagnosed with prostate cancer,
doi_str_mv 10.4103/1008-682X.135128
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0810d34057974fefa2f31445b6ab2278</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A417599084</galeid><cqvip_id>663375056</cqvip_id><doaj_id>oai_doaj_org_article_0810d34057974fefa2f31445b6ab2278</doaj_id><sourcerecordid>A417599084</sourcerecordid><originalsourceid>FETCH-LOGICAL-c568t-7f7a314b65cb5e75e898f3ea59b010b69c1727582ed45359038ab49245353bc53</originalsourceid><addsrcrecordid>eNptkktv1DAUhSMEoqWwZ4UikCo2M_htZ1OpqlpoVYkNSOwsx3EyHiV2aidI_HtumOnQQciLOL7fPbaPT1G8xWjNMKKfMEJqJRT5scaUY6KeFadYMr6SRJDnMH8snxSvct4iRCiuqpfFCeEEJkieFnc3PjQ-dLlsUxxKU44p5slMrrQmWJfKbJNzAYil0iUzlD4AdmdGE1x25RjHuTeTj-F18aI1fXZv9t-z4vvN9berL6v7r59vry7vV5YLNa1kKw3FrBbc1txJ7lSlWuoMr2qEUS0qiyWRXBHXME55hagyNavI8kNry-lZcbvTbaLZ6jH5waRfOhqv_yzE1GmTJm97p5HCqKEMcVlJ1rrWkBa2ZrwWpiZEKtC62GmNcz24xrowJdMfiR5Xgt_oLv7UjFBB2XKYj3uBFB9mlyc9-Gxd34M7cc4aC4K4EpUQgH74B93GOQWwSmOJJKrgsPIv1Rm4gA9thH3tIqovGZYcnk0xoNb_oWA0bvA2Btd6WD9qOH_SsHGmnzY59vPycPkYRDvQQhBycu3BDIz0Ejq9pEovqdK70EHLu6cmHhoeUwbA-73mJobuAcJ0YMAXKjnigv4GZrLZJg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1707098107</pqid></control><display><type>article</type><title>Findings from a prostate cancer screening program in a Japanese population</title><source>Open Access: PubMed Central</source><creator>Ranasinghe, Weranja K B ; Persad, Raj</creator><creatorcontrib>Ranasinghe, Weranja K B ; Persad, Raj</creatorcontrib><description>Although Asia has a very low incidence of prostate cancer in comparison with other Asian countries, Japan has one of the highest incidence （30.4 per 100 000） and mortality rates （5 per 100 000） from prostate cancer, according to the 2012 GLOBOCAN estimates. Kitagawa et al. conducted a retrospective analysis of the populationbased trends of prostate-specific antigen （PSA） screening conducted in men, between the ages of 54 and 69 years in Kanazawa city, which comprises of about a third of the Japanese population. In this annual screening program, they demonstrated a decreasing trend in the median serum PSA levels in men diagnosed with prostate cancer,</description><identifier>ISSN: 1008-682X</identifier><identifier>EISSN: 1745-7262</identifier><identifier>DOI: 10.4103/1008-682X.135128</identifier><identifier>PMID: 25219907</identifier><language>eng</language><publisher>China: Medknow Publications and Media Pvt. Ltd</publisher><subject>Cancer screening ; Humans ; Invited ; Male ; Mortality ; Prostate cancer ; Prostate-Specific Antigen - blood ; Prostatic Neoplasms - immunology ; PSA ; 亚洲国家 ; 人口 ; 前列腺癌 ; 发病率 ; 日本 ; 特异性抗原 ; 筛查</subject><ispartof>Asian journal of andrology, 2014-11, Vol.16 (6), p.922-922</ispartof><rights>COPYRIGHT 2014 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications &amp; Media Pvt Ltd Nov 2014</rights><rights>Copyright: © Asian Journal of Andrology 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c568t-7f7a314b65cb5e75e898f3ea59b010b69c1727582ed45359038ab49245353bc53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84127X/84127X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236345/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236345/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25219907$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ranasinghe, Weranja K B</creatorcontrib><creatorcontrib>Persad, Raj</creatorcontrib><title>Findings from a prostate cancer screening program in a Japanese population</title><title>Asian journal of andrology</title><addtitle>Asian Journal of Andrology</addtitle><description>Although Asia has a very low incidence of prostate cancer in comparison with other Asian countries, Japan has one of the highest incidence （30.4 per 100 000） and mortality rates （5 per 100 000） from prostate cancer, according to the 2012 GLOBOCAN estimates. Kitagawa et al. conducted a retrospective analysis of the populationbased trends of prostate-specific antigen （PSA） screening conducted in men, between the ages of 54 and 69 years in Kanazawa city, which comprises of about a third of the Japanese population. In this annual screening program, they demonstrated a decreasing trend in the median serum PSA levels in men diagnosed with prostate cancer,</description><subject>Cancer screening</subject><subject>Humans</subject><subject>Invited</subject><subject>Male</subject><subject>Mortality</subject><subject>Prostate cancer</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostatic Neoplasms - immunology</subject><subject>PSA</subject><subject>亚洲国家</subject><subject>人口</subject><subject>前列腺癌</subject><subject>发病率</subject><subject>日本</subject><subject>特异性抗原</subject><subject>筛查</subject><issn>1008-682X</issn><issn>1745-7262</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkktv1DAUhSMEoqWwZ4UikCo2M_htZ1OpqlpoVYkNSOwsx3EyHiV2aidI_HtumOnQQciLOL7fPbaPT1G8xWjNMKKfMEJqJRT5scaUY6KeFadYMr6SRJDnMH8snxSvct4iRCiuqpfFCeEEJkieFnc3PjQ-dLlsUxxKU44p5slMrrQmWJfKbJNzAYil0iUzlD4AdmdGE1x25RjHuTeTj-F18aI1fXZv9t-z4vvN9berL6v7r59vry7vV5YLNa1kKw3FrBbc1txJ7lSlWuoMr2qEUS0qiyWRXBHXME55hagyNavI8kNry-lZcbvTbaLZ6jH5waRfOhqv_yzE1GmTJm97p5HCqKEMcVlJ1rrWkBa2ZrwWpiZEKtC62GmNcz24xrowJdMfiR5Xgt_oLv7UjFBB2XKYj3uBFB9mlyc9-Gxd34M7cc4aC4K4EpUQgH74B93GOQWwSmOJJKrgsPIv1Rm4gA9thH3tIqovGZYcnk0xoNb_oWA0bvA2Btd6WD9qOH_SsHGmnzY59vPycPkYRDvQQhBycu3BDIz0Ejq9pEovqdK70EHLu6cmHhoeUwbA-73mJobuAcJ0YMAXKjnigv4GZrLZJg</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Ranasinghe, Weranja K B</creator><creator>Persad, Raj</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt Ltd</general><general>Wolters Kluwer Medknow Publications</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20141101</creationdate><title>Findings from a prostate cancer screening program in a Japanese population</title><author>Ranasinghe, Weranja K B ; Persad, Raj</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c568t-7f7a314b65cb5e75e898f3ea59b010b69c1727582ed45359038ab49245353bc53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Cancer screening</topic><topic>Humans</topic><topic>Invited</topic><topic>Male</topic><topic>Mortality</topic><topic>Prostate cancer</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostatic Neoplasms - immunology</topic><topic>PSA</topic><topic>亚洲国家</topic><topic>人口</topic><topic>前列腺癌</topic><topic>发病率</topic><topic>日本</topic><topic>特异性抗原</topic><topic>筛查</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ranasinghe, Weranja K B</creatorcontrib><creatorcontrib>Persad, Raj</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>维普中文期刊数据库</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest - Health &amp; Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Asian journal of andrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ranasinghe, Weranja K B</au><au>Persad, Raj</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Findings from a prostate cancer screening program in a Japanese population</atitle><jtitle>Asian journal of andrology</jtitle><addtitle>Asian Journal of Andrology</addtitle><date>2014-11-01</date><risdate>2014</risdate><volume>16</volume><issue>6</issue><spage>922</spage><epage>922</epage><pages>922-922</pages><issn>1008-682X</issn><eissn>1745-7262</eissn><abstract>Although Asia has a very low incidence of prostate cancer in comparison with other Asian countries, Japan has one of the highest incidence （30.4 per 100 000） and mortality rates （5 per 100 000） from prostate cancer, according to the 2012 GLOBOCAN estimates. Kitagawa et al. conducted a retrospective analysis of the populationbased trends of prostate-specific antigen （PSA） screening conducted in men, between the ages of 54 and 69 years in Kanazawa city, which comprises of about a third of the Japanese population. In this annual screening program, they demonstrated a decreasing trend in the median serum PSA levels in men diagnosed with prostate cancer,</abstract><cop>China</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>25219907</pmid><doi>10.4103/1008-682X.135128</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1008-682X
ispartof Asian journal of andrology, 2014-11, Vol.16 (6), p.922-922
issn 1008-682X
1745-7262
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_0810d34057974fefa2f31445b6ab2278
source Open Access: PubMed Central
subjects Cancer screening
Humans
Invited
Male
Mortality
Prostate cancer
Prostate-Specific Antigen - blood
Prostatic Neoplasms - immunology
PSA
亚洲国家
人口
前列腺癌
发病率
日本
特异性抗原
筛查
title Findings from a prostate cancer screening program in a Japanese population
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T03%3A03%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Findings%20from%20a%20prostate%20cancer%20screening%20program%20in%20a%20Japanese%20population&rft.jtitle=Asian%20journal%20of%20andrology&rft.au=Ranasinghe,%20Weranja%20K%20B&rft.date=2014-11-01&rft.volume=16&rft.issue=6&rft.spage=922&rft.epage=922&rft.pages=922-922&rft.issn=1008-682X&rft.eissn=1745-7262&rft_id=info:doi/10.4103/1008-682X.135128&rft_dat=%3Cgale_doaj_%3EA417599084%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c568t-7f7a314b65cb5e75e898f3ea59b010b69c1727582ed45359038ab49245353bc53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1707098107&rft_id=info:pmid/25219907&rft_galeid=A417599084&rft_cqvip_id=663375056&rfr_iscdi=true